PepperPV, OwensDK.Cost-effectiveness of the pneumococcal vaccine in healthy younger adults.Med Decis Making.2002; 22(Suppl): S45–S57.
2.
CorsoPS, ThackerSB, KoplanJP.The value of prevention: experiences of a public health agency.Med Decis Making.2002; 22(Suppl): S11–S16.
3.
HupertN, MushlinAI, CallahanMA.Modeling the public health response to bioterrorism: using discrete event simulation to design antibiotic distribution centers.Med Decis Making.2002; 22(Suppl): S17–S25.
4.
SongF, RafteryJ, AveyardP, HydeC, BartonP, WoolacottN.Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.Med Decis Making.2002; 22(Suppl): S26–S37.
5.
MrusJM, YiMS, EckmanMH, TsevatJ.The impact of expected HIV transmission rates on the effectiveness and cost of ruling out HIV infection in infants.Med Decis Making.2002; 22(Suppl): S38–S44.
6.
AhmedF, ElbashaEE, ThompsonBL, HarrisJR, SnellerV-P.Cost-benefit analysis of a new HEDIS performance measure for pneumococcal vaccination.Med Decis Making.2002; 22(Suppl): S58–S66.
7.
MansleyEC, DuñetDO, MayDS, ChattopadhyaySK, McKennaMT.Variation in average costs among federally sponsored state-organized cancer detection programs: economies of scale?Med Decis Making.2002; 22(Suppl): S67–S79.
8.
EarnshawSR, RichterA, SorensenSWOptimal allocation of resources across four interventions for type 2 diabetes.Med Decis Making.2002; 22(Suppl): S80–S91.
9.
CorsoPS, HammittJK, GrahamJD, DickerRC, GoldieSJ.Assessing preferences for prevention versus treatment using willingness to pay.Med Decis Making.2002; 22(Suppl): S92–S101.
10.
DionM-J, TousignantP, BourbeauJ, MenziesD, SchwartzmanK.Measurement of health preferences among patients with tuberculosis infection and disease.Med Decis Making.2002; 22(Suppl): S102–S114.
11.
OwensDK, SoxHC.Medical decision making: probabilistic medical reasoning. In: ShortliffeEH, PerreaultLE, FaganLM, WiederholdG, editors. Medical Informatics Computer Applications in Health Care.2nd ed.New York: Springer-Verlag;2000. p. 76–131.
12.
NeaseRFJr., OwensDK.Use of influence diagrams to structure medical decisions.Med Decis Making.1997; 17: 263–75.
13.
OwensDK, ShachterRD, NeaseRFJr.,. Representation and analysis of medical decision problems with influence diagrams.Med Decis Making.1997; 17: 241–62.
14.
Centers for Disease Control and Prevention.Revised guidelines for HIV counseling, testing, and referral and revised recommendations for HIV screening of pregnant women.MMWR.2001; 50(No. RR-19): 1–86.
15.
Centers for Disease Control and Prevention.Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings.MMWR.1993; 42(No. RR-2): 1–6.
16.
OwensDK, NeaseRFJr., HarrisRA.Cost-effectiveness of HIV screening in acute care settings.Arch Intern Med.1996; 156: 394–404.
17.
NaimarkD, KrahnMD, NaglieG, RedelmeierDA, DetskyAS.Primer on medical decision analysis: part 5-working with Markov processes.Med Decis Making.1997; 17: 152–9.
18.
KrahnMD, NaglieG, NaimarkD, RedelmeierDA, DetskyAS.Primer on medical decision analysis: part 4-analyzing the model and interpreting the results.Med Decis Making.1997; 17: 142–51.
19.
NaglieG, KrahnMD, NaimarkD, RedelmeierDA, DetskyAS.Primer on medical decision analysis: part 3-estimating probabilities and utilities.Med Decis Making.1997; 17: 136–41.
20.
DetskyAS, NaglieG, KrahnMD, RedelmeierDA, NaimarkD.Primer on medical decision analysis: part 2-building a tree.Med Decis Making.1997; 17: 126–35.
21.
DetskyAS, NaglieG, KrahnMD, NaimarkD, RedelmeierDA.Primer on medical decision analysis: part 1-getting started.Med Decis Making.1997; 17: 123–5.
22.
HuninkMGM, GlasziouPP, SiegelJEDecision Making in Health and Medicine: Integrating Evidence and Values.Cambridge, UK: Cambridge University Press;2001.
23.
SonnenbergFA, BeckJR.Markov models in medical decision making: a practical guide.Med Decis Making.1993; 13: 322–38.
24.
GarberAM, LittenbergB, SoxHCJr., WagnerJL, GluckM.Costs and health consequences of cholesterol screening for a symptomatic older Americans.Arch Intern Med.1991; 151: 1089–95.
25.
GarberAM, PhelpsCE.Economic foundations of cost-effectiveness analysis.J Health Econ.1997; 16: 1–31.
26.
OwensDK.Interpretation of cost-effectiveness analyses.J Gen Intern Med.1998; 13: 716–7.
27.
StonePW, TeutschS, ChapmanRH, BellC, GoldieSJ, NeumannPJ.Cost-utility analyses of clinical preventive services: published ratios, 1976-1997.Am J Prev Med.2000; 19: 15–23.
